Online Inquiry
Cat.#: ACPP-1555
| Despition | TGFBI Human Recombinant, 182 a.a. |
| SIZE | 10 µg |
| Purity | > 95.0% (SDS-PAGE) |
| Form | Sterile filtered liquid formulation. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1297 | p75 NGF Receptor Blocking Peptide (AC1297) | 250 µg | inquiry |
| ACPP-1569 | Human SOX2 Protein (AC1569) | 5 µg | inquiry |
| ACPP-1216 | PARD3 Blocking Peptide (AC1216) | 250 µg | inquiry |
| ACPP-1636 | Vasopressin (AC1636) | 5 mg | inquiry |
| ACPP-1011 | Recombinant Human FGF1 Protein (AC1011) | 50 µg | inquiry |
| ACPP-1233 | Galectin 3 Blocking Peptide (AC1233) | 250 µg | inquiry |
| ACPP-1101 | Recombinant Human SIRP alpha Protein (Fc Tag) (AC1101) | 50 µg | inquiry |
| ACPP-1804 | Human STMN2 Protein (AC1804) | 2 µg | inquiry |
| ACPP-1191 | Nogo Blocking Peptide (AC1191) | 250 µg | inquiry |
| ACPP-1586 | Human SERPINI1 Protein (AC1586) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.